论文部分内容阅读
在200多年的历史中,杜邦经历过几次转型,从最初的火药业务,到转型做化工,再到现在面临着第三次转型,成为一家科学公司。目前,杜邦约有1/3的营业额来自于非传统的化工领域。为了适应市场的需求,未来十年,将会有更多的业务来自非传统的化工领域。2011年,杜邦完成了对丹尼斯克的收购,将丹尼斯克旗下的杰能科酶制剂业务与杜邦原有的应用
In more than 200 years of history, DuPont has undergone several transformations, from the initial gunpowder business to the transformation of chemical industry. Now it is facing a third transformation and becoming a science company. Currently, about one-third of DuPont’s turnover comes from the non-traditional chemical industry. In order to meet the needs of the market, in the next ten years, more businesses will come from non-traditional chemical fields. In 2011, DuPont completed the acquisition of Danisco, Deniske’s Genencor enzyme business and DuPont’s original application